Cellebrite DI Statistics
Total Valuation
Cellebrite DI has a market cap or net worth of $4.19 billion. The enterprise value is $3.62 billion.
| Market Cap | 4.19B |
| Enterprise Value | 3.62B |
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cellebrite DI has 244.47 million shares outstanding. The number of shares has increased by 22.84% in one year.
| Current Share Class | 244.47M |
| Shares Outstanding | 244.47M |
| Shares Change (YoY) | +22.84% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 46.48% |
| Float | 117.43M |
Valuation Ratios
The trailing PE ratio is 54.76 and the forward PE ratio is 32.66. Cellebrite DI's PEG ratio is 1.98.
| PE Ratio | 54.76 |
| Forward PE | 32.66 |
| PS Ratio | 8.97 |
| Forward PS | 7.76 |
| PB Ratio | 9.32 |
| P/TBV Ratio | 10.24 |
| P/FCF Ratio | 29.88 |
| P/OCF Ratio | 27.44 |
| PEG Ratio | 1.98 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.19, with an EV/FCF ratio of 25.78.
| EV / Earnings | 47.38 |
| EV / Sales | 7.93 |
| EV / EBITDA | 50.19 |
| EV / EBIT | 58.90 |
| EV / FCF | 25.78 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.11 |
| Quick Ratio | 1.99 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 20.46% and return on invested capital (ROIC) is 9.84%.
| Return on Equity (ROE) | 20.46% |
| Return on Assets (ROA) | 5.24% |
| Return on Invested Capital (ROIC) | 9.84% |
| Return on Capital Employed (ROCE) | 11.87% |
| Revenue Per Employee | $390,662 |
| Profits Per Employee | $65,410 |
| Employee Count | 1,167 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 7.96 |
Taxes
In the past 12 months, Cellebrite DI has paid $7.97 million in taxes.
| Income Tax | 7.97M |
| Effective Tax Rate | 9.45% |
Stock Price Statistics
The stock price has decreased by -15.06% in the last 52 weeks. The beta is 1.28, so Cellebrite DI's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -15.06% |
| 50-Day Moving Average | 17.82 |
| 200-Day Moving Average | 17.28 |
| Relative Strength Index (RSI) | 48.86 |
| Average Volume (20 Days) | 1,476,566 |
Short Selling Information
The latest short interest is 7.59 million, so 3.10% of the outstanding shares have been sold short.
| Short Interest | 7.59M |
| Short Previous Month | 6.33M |
| Short % of Shares Out | 3.10% |
| Short % of Float | 6.46% |
| Short Ratio (days to cover) | 5.32 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of $455.90 million and earned $76.33 million in profits. Earnings per share was $0.31.
| Revenue | 455.90M |
| Gross Profit | 382.80M |
| Operating Income | 61.40M |
| Pretax Income | 84.30M |
| Net Income | 76.33M |
| EBITDA | 72.06M |
| EBIT | 61.40M |
| Earnings Per Share (EPS) | $0.31 |
Balance Sheet
The company has $525.71 million in cash and $21.44 million in debt, giving a net cash position of $573.85 million or $2.35 per share.
| Cash & Cash Equivalents | 525.71M |
| Total Debt | 21.44M |
| Net Cash | 573.85M |
| Net Cash Per Share | $2.35 |
| Equity (Book Value) | 447.69M |
| Book Value Per Share | 1.84 |
| Working Capital | 351.49M |
Cash Flow
In the last 12 months, operating cash flow was $152.70 million and capital expenditures -$12.45 million, giving a free cash flow of $140.25 million.
| Operating Cash Flow | 152.70M |
| Capital Expenditures | -12.45M |
| Free Cash Flow | 140.25M |
| FCF Per Share | $0.57 |
Margins
Gross margin is 83.96%, with operating and profit margins of 13.47% and 16.74%.
| Gross Margin | 83.96% |
| Operating Margin | 13.47% |
| Pretax Margin | 18.49% |
| Profit Margin | 16.74% |
| EBITDA Margin | 15.80% |
| EBIT Margin | 13.47% |
| FCF Margin | 30.76% |
Dividends & Yields
Cellebrite DI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.84% |
| Shareholder Yield | -22.84% |
| Earnings Yield | 1.82% |
| FCF Yield | 3.35% |
Analyst Forecast
The average price target for Cellebrite DI is $24.40, which is 42.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.40 |
| Price Target Difference | 42.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 17.04% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellebrite DI has an Altman Z-Score of 7.67 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.67 |
| Piotroski F-Score | 5 |